-
AskBio Awarded £2m Scottish Enterprise R&D Grant to Help Reduce Barriers to Mainstream Gene Therapy
Edinburgh, UK, 2nd September 2020 / Sciad Newswire / Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage gene therapy company dedicated to developing adeno-associated virus (AAV) gene therapies for genetic disorders, announces the award of a £1.99m R&D Grant from Scottish Enterprise. AskBio will invest £3.4m alongside the grant to fund research into the manufacturing challenges associated with…
-
LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy
Amsterdam, the Netherlands, 3rd August 2020 / Sciad Newswire / LUMICKS has entered into a collaboration with Glycostem Therapeutics, the Netherlands, to improve immunotherapeutic drug development. By quantifying binding strength between immune and cancer cells using the unique z-Movi® Cell Avidity Analyzer, Glycostem exploits the predictiveness of avidity in finding the best NK-cell population for cellular therapy. Glycostem is…
-
SkinCheck affordable skin cancer screening re-opens
Check4Cancer re-opens ‘SkinCheck’ clinics to provide skin cancer screening during COVID. Cambridge, UK, 3rd August 2020 / Sciad Newswire / Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, is reopening its SkinHealth SkinCheck clinics following enforced closure due to COVID-19. The clinics are now open, with additional safety precautions…
-
Teaming up to make CPD easier
ClinOwl and OpenAthens join forces to help HCPs find the most relevant, trustworthy research. Medical research is progressing at an ever-increasing rate; the last ten years alone have seen countless transformative advances, changing the way we research and develop medicines. This has never been more evident than during the current COVID-19 pandemic where we have…
-
Smarter Soup start-up raises capital to help reduce risk of diabetes
Norwich, UK, 21st July 2020 / Sciad Newswire / The Smarter Food Company has raised £1m in funding to accelerate the development of food products with health benefits. Its first product will be a vegetable-based soup containing glucoraphanin, a naturally occurring compound found in broccoli. The Company was founded on clinical data that suggests that a single weekly…
-
New Certa Plus sinusoidal pump – a best in class, sustainable solution for shear sensitive, viscous pharmaceutical products
Falmouth, UK, 20th July 2020 / Sciad Newswire / Watson-Marlow Fluid Technology Group (WMFTG) announces the launch of its new Certa Plus pump series to provide sustainable, high quality, versatile fluid management for the pharmaceutical industry. Certa Plus utilises MasoSine’s considerable experience in sinusoidal pumping technology to meet a broad range of applications. An innovative advancement over conventional…
-
New Certa Plus sinusoidal pump – a best in class, sustainable solution for shear sensitive, viscous pharmaceutical products
Falmouth, UK, 20th July 2020 / Sciad Newswire / Watson-Marlow Fluid Technology Group (WMFTG) announces the launch of its new Certa Plus pump series to provide sustainable, high quality, versatile fluid management for the pharmaceutical industry. Certa Plus utilises MasoSine’s considerable experience in sinusoidal pumping technology to meet a broad range of applications. An innovative advancement over conventional lobe pumps, the new sinusoidal Certa Plus…
-
Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia
San Diego, California and Saffron Walden, UK, 14th July 2020 / Sciad Newswire / Invivoscribe, Inc., an industry pioneer and global leader in the field of precision diagnostics announces the launch of a fully integrated drug development engine. This new engine will combine with its in-house expertise in diagnostics development and worldwide access to patients and clinical testing capabilities…
-
Audit of Check4Cancer’s One Stop Breast Clinic network confirms clinical excellence in the private sector
Cambridge, UK, 14th July 2020 / Sciad Newswire / Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, announces audit results from its private breast cancer diagnostic pathway, confirming Check4Cancer’s One Stop Breast Clinic network provides clinical excellence for patients experiencing symptoms of breast cancer. The audit of over 4400 patients, published in the European…
-
Atelerix and Perfectus Biomed Group collaborate to improve the storage of COVID-19 test swabs
London, UK, 22nd June 2020 / Sciad Newswire / The UK Innovation and Science Seed Fund (UKI2S) is delighted to announce the collaboration of Atelerix and Perfectus Biomed Group, two of UKI2S’s portfolio companies. In May 2020, Atelerix announced that it had secured a government backed, Innovate UK grant to extend the shelf life of COVID-19 test kits. A severe limitation of swab samples is their…